fibrinogen has been researched along with Adenocarcinoma of Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T; Liu, YJ; Ma, N; Shi, AP; Shu, C; Tang, XY; Xiong, YL; Yang, J; Zhao, JB; Zhao, YB; Zheng, KF | 1 |
| Deng, Y; Jiang, N; Li, P; Li, Y; Luo, J; Tian, Z; Xiao, Z; Zhang, W; Zhao, J; Zhao, X; Zhao, Y; Zhou, J; Zhou, Y | 1 |
| Cao, C; Jiang, X; Liu, S; Lu, S; Niu, X; Qiao, Z; Shang, Z; Xiao, H; Zhang, K | 1 |
| Hou, T; Hu, C; Liu, P; Liu, X; Ma, J; Zhang, H; Zhang, N; Zhao, X | 1 |
| He, Q; Hu, A; Li, J; Li, Y; Peng, S; Xia, C; Zhang, R; Zhang, Z; Zhou, W; Zhou, X | 1 |
| Amir, ZC; Aouichat-Bouguerra, S; Ferhat-Hamida, MY; Hammouda, A; Hariti, G; Souilah, S | 1 |
| Bie, F; Du, J; Huang, C; Qu, X; Wang, G; Wang, Y | 1 |
7 other study(ies) available for fibrinogen and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1-FGL1-MYH9 axis.
Topics: Adenocarcinoma of Lung; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Interleukin-2; Lung Neoplasms; Myosin Heavy Chains; YY1 Transcription Factor | 2022 |
Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression.
Topics: Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Hippo Signaling Pathway; Humans; Lung Neoplasms; Mice; MicroRNAs; RNA, Circular; Tumor Microenvironment | 2023 |
FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Female; Fibrinogen; Hepatocytes; Humans; Immunoprecipitation; Lung Neoplasms; Male; Mass Spectrometry; Middle Aged; Molecular Targeted Therapy; Protein Array Analysis; Protein Isoforms; Protein Kinase Inhibitors; Proteomics | 2019 |
High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments.
Topics: Adenocarcinoma of Lung; Biomarkers; Blood Cell Count; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Fibrinogen; Humans; Male; Middle Aged; Mutation; Predictive Value of Tests; Prognosis; Progression-Free Survival; Protein Kinase Inhibitors; Serum Albumin, Human | 2020 |
The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fibrinogen; Humans; Lung Neoplasms; Lymphocytes; Neutrophils; Prognosis; Protein Kinase Inhibitors; Retrospective Studies | 2021 |
[Activation of coagulation in patients with lung cancer].
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Platelet Activation; Prognosis | 2019 |
Loss of FGL1 induces epithelial‑mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Topics: A549 Cells; Adenocarcinoma of Lung; Adult; AMP-Activated Protein Kinase Kinases; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Fibrinogen; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neovascularization, Pathologic; Protein Serine-Threonine Kinases | 2019 |